Alivus Life Sciences informs about board meeting

16 Jan 2025 Evaluate
Alivus Life Sciences has informed that, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Thursday, January 23, 2025, to consider and approve the Unaudited Financial Results of the Company for the third quarter and nine months ended 31st December, 2024. Further, as per the Code of Conduct for Prevention of Insider Trading and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has intimated its ‘designated persons’ regarding the closure of the Trading Window from December 31, 2024 to January 25, 2025 (both days inclusive) for the purpose of approval of Unaudited Financial Results for third quarter and nine months ended December 31, 2024.

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

920.80 5.30 (0.58%)
02-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.90
Dr. Reddys Lab 1182.35
Cipla 1311.75
Zydus Lifesciences 879.25
Lupin 2128.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×